5-HT1A receptors play an important role in modulation of behavior of rats in a two-compartment black and white box

Behavioural Pharmacology

Volumn 7, Issue 8, 1996, Pages 788-797

  Sanchez C ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

5 HT; Anxiety; Black and white test box; Rat; Receptor; Subtypes

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; BUSPIRONE; DIAZEPAM; ELTOPRAZINE; FENCLONINE METHYL ESTER; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ONDANSETRON; PARTIAL AGONIST; RECEPTOR SUBTYPE; RITANSERIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1C RECEPTOR; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2C AGONIST; SEROTONIN 2C ANTAGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN RECEPTOR AFFECTING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; EXPLORATORY BEHAVIOR; MALE; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TRANQUILIZING ACTIVITY;

EID: 0030426562     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. 2 agonist DOI. European Journal of Pharmacology, 161, 45-51.
2. 1A receptors. British Journal of Pharmacology, 100, 793-799.
3. 2 antagonist WY-50,324 in pigeons. Drug Development Research, 24, 179-188.
4. 1A antagonist, WAY-100635, in functional and anxiety models. Behavioural Pharmacology, 5, 77.
5. Briley M, Chopin P and Moret C (1991) The role of serotonin in anxiety: behavioural approaches. In: New Concepts in Anxiety (Eds M Briley and SE File), pp. 56-73. MacMillan Press.
6. Carli M, Prontera C and Samanin R (1989) Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone. British Journal of Pharmacology, 96, 829-836.
7. Colpaert FC, Meert TF, Niemegeers CJE and Janssen PAJ (1985) Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat. Psychopharmacology, 86, 45-54.
8. 3 receptor antagonists. Pharmacology and Toxicology, 70, 157-162.
9. Costall B, Kelly ME, Naylor RJ and Onaivi ES (1988) Actions of buspirone in a putative model of anxiety in the mouse. Journal of Pharmacy and Pharmacology, 40, 494-500.
10. Costall B, Jones BJ, Kelly ME, Naylor RJ and Tomkins DM (1989) Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacology, Biochemistry and Behavior, 32, 777-785.
11. Crawley JN (1981) Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacology, Biochemistry and Behavior, 15, 695-699.
12. Crawley J and Goodwin FK (1980) Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacology, Biochemistry and Behavior, 13, 167-170.
13. 1A receptor antagonist WAY 100635. European Journal of Pharmacology, 264, 95-97.
14. 2 receptors? Pharmacology, Biochemistry and Behavior, 36, 901-906.
15. 2 receptor antagonist. Society for Neuroscience Abstracts, 16, 1037.
16. 3 antagonists ondansetron, zacopride, 3α-tropanyl-1-H-indole-3-carboxylic acid ester, and 1αH, 3α, 5αH-tropan-3-yl-3,5-dichlorobenzoate. Drug Development Research, 23, 289-300.
17. Fernández-Guasti A, Hong E and López-Rubalcava C (1992) Species differences in the mechanism through which the serotonergic agonists indorenate and ipsapirone produce their anxiolytic action. Psychopharmacology, 107, 61-68.
18. 1A receptor antagonist. British Journal of Pharmacology, 112, 91P.
19. Griebel G, Saffroy-Spittler M, Misslin R, Vogel E and Martin JR (1990) Serenics fluprazine (DU 27716) and eltoprazine (DU 28853) enhance neophoric and emotional behaviour in mice. Psychopharmacology, 102, 498-502.
20. 1A receptor antagonist WAY-100635 on hippocampal 5-HT release in vivo. British Journal of Pharmacology, 112, 299P.
21. 1A receptor antagonist, on feeding and 8-OH-DPAT-induced feeding in the rat. British Journal of Pharmacology, 112, 298P.
22. Herndon JL, Pierson ME and Glennon RA (1992) Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl)piperazine. Pharmacology, Biochemistry and Behavior, 43, 739-748.
23. 2B receptor antagonist with anxiolytic-like properties. British Journal of Pharmacology, 117, 427-434.
24. Kilfoil T, Michel A, Montgomery D and Whiting RL (1989) Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice. Neuropharmacology, 28, 901-905.
25. Kshama D, Hrishikeshavan HJ, Shanbhogue R and Munonyedi US (1990) Modulation of baseline behavior in rats by putative serotonergic agents in three ethoexperimental paradigms. Behavioral and Neural Biology, 54, 234-253.
26. López-Rubalcava C, Saldívar A and Fernández-Guasti A (1992) Interaction of GABA and serotonin in the anxiolytic action of diazepam and serotonergic anxiolytics. Pharmacology, Biochemistry and Behavior, 43, 433-440.
27. 1A ligands, 8-OH-DPAT and MDL 73005EF, in mice. Neuroreport, 1, 267-270.
28. 3 receptor antagonists, GR 38032F and BRL 24924, on anxiety in socially isolated rats. British Journal of Pharmacology, 97, 457.
29. Onaivi ES and Martin BR (1989) Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety. Progress in Neuro-Psychopharmacologv and Biological Psychiatry, 13, 963-976.
30. Onaivi ES, Bishop-Robinson B, Darmani NA and Sanders-Bush E (1995) Behavioral effects of (±)-1-(2,5-demethoxy-4-iodophenyl)-2-aminopropane (DOI) in the elevated plus-maze test. Life Sciences, 57, 2455-2466.
31. Pich EM and Samanin R (1989) A two-compartment exploratory model to study anxiolytic/anxiogenic effects of drugs in the rat. Pharmacological Research, 21, 595-602.
32. Rodgers RJ, Cole JC, Cobain MR, Daly P, Doran PJ, Eells JR and Wallis P (1992) Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP. Behavioural Pharmacology, 3, 621-634.
33. Routledge C, Gurling J, Ashworth-Preece MA and Dourish CT (1995) Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190. European Journal of Pharmacology, 276, 281-284.
34. Sánchez C (1995) Serotonergic mechanisms involved in the exploratory behaviour of mice in a fully automated two-compartment black and white test box. Pharmacology and Toxicology, 77, 71-78.
35. Sánchez C, Arnt J, Costall B, Domeney AM, Kelly E and Naylor RJ (1995) Sertindole: a limbic selective neuroleptic with potent anxiolytic effects. Drug Development Research, 34, 19-29.
36. 1B receptor ligands exist? Naunyn-Schmiedebergs Archives of Pharmacology, 339, 675-683.
37. 1A receptor ligands in animal models of anxiety, impulsivity and depression: multiple mechanisms of action? Progress in Neuro-Psychopharmacology and Biological Psychiatry, 17, 87-104.
38. 1A receptor. Behavioural Pharmacology, 5, 82.
39. Shimada T, Matsumoto K, Osanal M, Matsuda H, Terasawa K and Watanabe H (1995) The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs. General Pharmacology, 26, 205-210.
40. 1B receptor subtypes in rat brain: sensitivity to guanine nucleotides. European Journal of Pharmacology, 187, 209-223.
41. 1 receptor sites in the rat brain: an autoradiographic study. European Journal of Pharmacology, 177, 55-66.
42. 1A receptor antagonist in the conditioned emotional response test in rats. Behavioural Pharmacology, 5, 32.
43. VanderMaelen CP, Matheson GK, Wilderman RC and Patterson LA (1986) Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. European Journal of Pharmacology, 129, 123-130.
44. Yocca FD, Wright RN, Margraf RR and Eison AS (1990) 8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats. Pharmacology, Biochemistry and Behavior, 35, 251-254.
45. Young R and Johnson DN (1991) Comparison of routes of administration and time course effects of zacopride and buspirone in mice using an automated light/dark test. Pharmacology, Biochemistry and Behavior, 40, 733-737.